518 related articles for article (PubMed ID: 37217354)
61. Comparison of overall survival of gastric neoplasms containing neuroendocrine carcinoma components with gastric adenocarcinoma: a propensity score matching study.
Chen J; Wang A; Ji K; Bu Z; Ji J
BMC Cancer; 2020 Aug; 20(1):777. PubMed ID: 32811471
[TBL] [Abstract][Full Text] [Related]
62. [Clinicopathologic characteristics and prognostic factors of gastric cancer in the elderly patients over 75 years].
Gao H; Lan X; Li S; Xue Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 May; 19(5):522-5. PubMed ID: 27215518
[TBL] [Abstract][Full Text] [Related]
63. [Comparison of clinicopathological features and prognosis between adenocarcinoma of esophagogastric junction and adenocarcinoma of gastric antrum].
Zhu Z; Wang Y; Li F; Gao J; Han B; Wang R; Xue Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):149-155. PubMed ID: 30799537
[TBL] [Abstract][Full Text] [Related]
64. Neuroendocrine Carcinoma of Gall Bladder: A Series of 19 Cases with Review of Literature.
Kamboj M; Gandhi JS; Gupta G; Sharma A; Pasricha S; Mehta A; Chandragouda D; Sinha R
J Gastrointest Cancer; 2015 Dec; 46(4):356-64. PubMed ID: 26208508
[TBL] [Abstract][Full Text] [Related]
65. Analysis of Clinicopathological Features and Prognostic Factors in 39 Cases of Bladder Neuroendocrine Carcinoma.
Zhou HH; Liu LY; Yu GH; Qu GM; Gong PY; Yu X; Yang P
Anticancer Res; 2017 Aug; 37(8):4529-4537. PubMed ID: 28739749
[TBL] [Abstract][Full Text] [Related]
66. Ampullary Neuroendocrine Neoplasm: Clinicopathological Characteristics and Novel Endoscopic Entity.
Matsumoto K; Fujimori N; Hata Y; Minoda Y; Murakami M; Teramatsu K; Takamatsu Y; Takeno A; Oono T; Ihara E; Nakata K; Nakamura M; Yamamoto T; Koga Y; Oda Y; Ito T; Ogawa Y
Dig Dis; 2023; 41(2):316-324. PubMed ID: 35588707
[TBL] [Abstract][Full Text] [Related]
67. [Efficacy comparison between surgical resection and endoscopic submucosal dissection of early gastric cancer in a domestic single center].
Rong L; Cai Y; Nian W; Wang X; Liang J; He Y; Zhang J
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):190-195. PubMed ID: 29492919
[TBL] [Abstract][Full Text] [Related]
68. Do neuroendocrine carcinomas and mixed neuroendocrine-non-neuroendocrine neoplasm of the gastrointestinal tract have the same prognosis? A
Shi H; Qi C; Meng L; Yao H; Jiang C; Fan M; Pang S; Zhang Q; Lin R
Ther Adv Endocrinol Metab; 2020; 11():2042018820938304. PubMed ID: 32670540
[TBL] [Abstract][Full Text] [Related]
69. Sporadic Gastric Well-Differentiated Neuroendocrine Tumors Have a Higher Ki-67 Proliferative Index.
Lee HE; Mounajjed T; Erickson LA; Wu TT
Endocr Pathol; 2016 Sep; 27(3):259-67. PubMed ID: 27306997
[TBL] [Abstract][Full Text] [Related]
70. Clinicopathological, treatment, and prognosis study of 43 gastric neuroendocrine carcinomas.
Liu DJ; Fu XL; Liu W; Zheng LY; Zhang JF; Huo YM; Li J; Hua R; Liu Q; Sun YW
World J Gastroenterol; 2017 Jan; 23(3):516-524. PubMed ID: 28210088
[TBL] [Abstract][Full Text] [Related]
71. Characteristics and prognosis of gastric cancer in patients aged ≥ 70 years.
Liang YX; Deng JY; Guo HH; Ding XW; Wang XN; Wang BG; Zhang L; Liang H
World J Gastroenterol; 2013 Oct; 19(39):6568-78. PubMed ID: 24151383
[TBL] [Abstract][Full Text] [Related]
72. Comparative Outcomes in Patients With Small- and Large-Cell Neuroendocrine Carcinoma (NEC) and Mixed Neuroendocrine-Non-Neuroendocrine Neoplasm (MiNEN) of the Stomach.
Choi NY; Kim BS; Oh ST; Yook JH; Kim BS
Am Surg; 2021 Apr; 87(4):631-637. PubMed ID: 33142079
[TBL] [Abstract][Full Text] [Related]
73. [Clinicopathological features and prognosis of different gastric carcinoid subtypes].
Liang JW; Zhou ZX; Liu Q; Bai XF; Zhao P
Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):866-9. PubMed ID: 19173835
[TBL] [Abstract][Full Text] [Related]
74. Treatment strategies for neuroendocrine carcinoma of the upper digestive tract.
Morita M; Taguchi K; Kagawa M; Nakanoko T; Uehara H; Sugiyama M; Ota M; Ikebe M; Sugimachi K; Esaki T; Toh Y
Int J Clin Oncol; 2020 May; 25(5):842-850. PubMed ID: 32036480
[TBL] [Abstract][Full Text] [Related]
75. [Outcomes and prognosis of radical surgery in patients with stageⅠb2 and Ⅱa2 cervical squamous cell carcinoma].
Zhou F; Chen F; Pan T; Zhu T; Zhang YL; Zhang P; Tang HR
Zhonghua Fu Chan Ke Za Zhi; 2022 May; 57(5):361-369. PubMed ID: 35658327
[No Abstract] [Full Text] [Related]
76. Clinical outcome and long-term survival of 150 consecutive patients with pancreatic neuroendocrine tumors: A comprehensive analysis by the World Health Organization 2010 grading classification.
Deng BY; Liu F; Yin SN; Chen AP; Xu L; Li B
Clin Res Hepatol Gastroenterol; 2018 Jun; 42(3):261-268. PubMed ID: 29307515
[TBL] [Abstract][Full Text] [Related]
77. Immunohistochemical consistency between primary tumors and lymph node metastases of gastric neuroendocrine carcinoma.
Uchiyama C; Tamura S; Nakatsuka S; Takeno A; Miki H; Kanemura T; Nakahira S; Suzuki R; Nakata K; Takeda Y; Kato T
World J Surg Oncol; 2012 Jun; 10():115. PubMed ID: 22726317
[TBL] [Abstract][Full Text] [Related]
78. [Clinical analysis of 29 cases with neuroendocrine neoplasm in the digestive system].
Liu Z; Li JQ; Tian DY; Yin XG; Zhang J; Liu G; Liang P; Bai YQ; Shen ZY; Hu X
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Nov; 16(11):1084-7. PubMed ID: 24277406
[TBL] [Abstract][Full Text] [Related]
79. Clinicopathologic features and lymph node metastasis pattern of the cervical MiNEN.
Xu H; Zhao Z; Zhu Y
Endocrine; 2022 May; 76(2):474-483. PubMed ID: 35102503
[TBL] [Abstract][Full Text] [Related]
80. Neuroendocrine Neoplasms of the Larynx: A Clinicopathologic Analysis of 27 Neuroendocrine Tumors and Neuroendocrine Carcinomas.
Bal M; Sharma A; Rane SU; Mittal N; Chaukar D; Prabhash K; Patil A
Head Neck Pathol; 2022 Jun; 16(2):375-387. PubMed ID: 34401980
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
